Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.

about

Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.

Item

http://www.wikidata.org/entity/Q47958014

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Raloxifene Improves Bone Mecha ...... usly Treated with Zoledronate.

@en

Raloxifene Improves Bone Mecha ...... usly Treated with Zoledronate.

@nl

type

Item

label

Raloxifene Improves Bone Mecha ...... usly Treated with Zoledronate.

@en

Raloxifene Improves Bone Mecha ...... usly Treated with Zoledronate.

@nl

prefLabel

Raloxifene Improves Bone Mecha ...... usly Treated with Zoledronate.

@en

Raloxifene Improves Bone Mecha ...... usly Treated with Zoledronate.

@nl

P1476

Raloxifene Improves Bone Mecha ...... ously Treated with Zoledronate

@en

P2093

Aryaman Gupta

http://www.w3.org/2001/XMLSchema#string

Cory N Meixner

http://www.w3.org/2001/XMLSchema#string

Drew Brown

http://www.w3.org/2001/XMLSchema#string

Matthew R Allen

http://www.w3.org/2001/XMLSchema#string

Mohammad W Aref

http://www.w3.org/2001/XMLSchema#string

P2860

Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones

In Vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal-Bound Water in Skeletally Mature Beagle Dogs.

Combination therapy for osteoporosis: a reappraisal

Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.

Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.

Bisphosphonate-induced reductions in rat femoral bone energy absorption and toughness are testing rate-dependent

A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years.

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

Bisphosphonates: the first 40 years.

Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.

P2888

s00223-017-0257-4

P304

75-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00223-017-0257-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Joseph M. Wallace

Erin M McNerny

P577

2017-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28246928

http://www.w3.org/2001/XMLSchema#string

P932

5459622

http://www.w3.org/2001/XMLSchema#string